Abstract
Background: Aceclofenac is a non-steroidal anti-inflammatory drug and a potent analgesic. However, its
oral ingestion may cause gastrointestinal problems, including dyspepsia, abnormal pain, nausea, diarrhea, and ulcerative
colitis.
Objective: This study aimed to prepare vesicular-based enteric microspheres containing aceclofenac by ionotropic
gelation technique to minimize gastric irritation in rats.
Methods: The micron-size vesicles were prepared by the ionic-orifice gelation method. Three types of vesicularbased
microcapsules containing aceclofenac were prepared by employing sodium alginate as the coating material in
combination with Eudragit L100, Eudragit S100, and polyvinylpyrrolidone PVP K90. The drug to sodium alginate to
polymer ratios were 1:0.5:0.5, 1:1:1, and 1:1.5:1.5, respectively. Gelation of sodium alginate was induced by the
dropwise addition of calcium chloride solution (10 % w/v). Aceclofenac-loaded microspheres were evaluated in
terms of aceclofenac content and in vitro drug release, and FTIR, DSC, and XRD were used for physicochemical
evaluation of some selected formulae. The effects of microencapsulation on aceclofenac-induced ulcerative activity
in male Wistar rats were also investigated.
Results: The results indicated no interaction between aceclofenac and microcapsules forming polymers. In addition,
microcapsules formulations M1, M4, and M7 gave maximal protection in acidic pH and optimal release in alkaline
pH. The histopathological studies revealed that the reduction of ulceration is evident from the macroscopic and microscopic
studies, which showed complete protection of the tissue morphology with no ulcers, indicating the effectiveness
of the microcapsules system against aceclofenac-induced gastric ulceration in rats again.
Conclusion: Ionotropic gelation seems to be a simple, efficient technique to prepare aceclofenac-loaded microspheres
with a reduced risk of gastric ulceration. It is possible to overcome the problem of gastric damage while
utilizing aceclofenac by avoiding the exposure of the drug to the ulcer-prone area of the gastrointestinal tract.
Keywords:
Aceclofenac, enteric microspheres, ionotropic gelation, in vitro release, induced gastric ulcer, rheumatoid arthritis.
[7]
Follonier, N.; Doelker, E. Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms. STP Pharma Sci., 1992, 2(2), 141-158.
[10]
Patil, J.S.; Kamalapur, M.V.; Marapur, S.C.; Kadam, D.V. Ionotropic gelation and polyelectrolyte complexation: The novel techniques to design hydrogel particulate sustained, modulated drug delivery system: A review. Dig. J. Nanomater. Biostruct., 2010, 5(1), 241-248.
[11]
Hemalatha, K.; Lathaeswari, R.; Suganeswari, M.; Kumar, S.V.; Shering, A.M. Formulation and evaluation of metoclopramide hydrochloride microbeads by ionotropic gelation method. Int. J. Pharm. Biol. Arch., 2011, 2, 921-925.
[13]
Sudhamani, T.; Reddy, K.N.; Kumar, V.R.; Revathi, R.; Ganesan, V. Preparation and evaluation of ethyl cellulose microspheres of Ibuprofen for sustained drug delivery. Int. J. Pharm. Res. Dev., 2010, 2(8), 119-125.
[16]
Dyer, J.R. Absorption of common functional groups.Application of absorption spectroscopy of organic compounds; 7th ed.; Prentice Hall of India, Pvt. Ltd: New Delhi, 1989, p. 32-37.
[19]
Zein, E.E.; Ossman, M.A.; Yassin, H.A. Al- rikaby, O. Effect of certain polymeric resins as well as water soluble carriers on the release of aceclofenac and its ulcerogenic activity in rats. Biom. Res.J., 2019, 1(2), 1-8.
[20]
John, I.D.; Harinath, N.M. Topical anti-inflammatory gels of fluocinolone acetonide entrapped in eudragit based micro sponge delivery system. Res. J. Pharm. Tech., 2008, 1(4), 502-506.
[21]
Ali, N.; Mitra, J.; Mohammed Reza, S.; Siavoosh, D. The Effect of formulation types on the release of benzoyl peroxide from micro sponges. Iran. J. Pharm. Sci., 2005, 1(3), 131-142.
[22]
Raval, M.K.; Bagda, A.A.; Patel, J.M.; Paun, J.S.; Shaudahari, K.R.; Sheth, N.R. Preparation and evaluation of sustained release ninmesulide microspheres using response surface methodology. J. Pharm. Res., 2010, 3(3), 581-586.
[30]
Swetha, A.; Gopal, R.M.; Ventaka, R.K.; Niyaz, B.B.; Koti, R.V. Preparation and evaluation of c Eudragit RS 100 microcapsules using quality by design approach. Int. J. Pharm., 2011, 1, 73-80.
[32]
Zien, E.; Ghorab, M.; Gad, S.; Yassin, H. Design and characterization of diclofenac sodium microspheres prepared by ionotropic gelation technique for oral controlled drug delivery. Int. J. Adv. Pharm. Biol. Chem., 2015, 4(2), 321-329.
[33]
Zien, E.; Ghorab, M.; Gad, S.; Yassin, H. Effect of certain polymers on the ulcerogenic activity of anon-steroidal anti-inflammatory drug. World J. Pharm. Res., 2015, 4(6), 2275-2290.
[35]
Korsmeyer, R.W.; Peppas, N.A. Macromolecular and modeling aspects of swelling-controlled systems. In: Controlled Release Delivery Systems; Roseman, T.G.; Mansdorf, S.Z., Eds.; Dekker, New York, 1983; pp. 77-101.
[36]
Jani, G.K.; Shah, D.P.; Prajapatia, V.D.; Jain, V.C. Gum and mucilages: Versatile excipients for pharmaceutical formulations. Asian J. Pharm. Sci., 2009, 4(5), 309-323.